@INRA B. Nicolas (veau dans la nursery à la ferme de Bressonvilliers)

VRSB SAPHIR Vaccine

Towards a new vaccine against bovine respiratory syncytial virus.

Developed as part of the European project SAPHIR, a vaccine agaist the bovine syncytial respiratory vaccine with only one administration has been shown to be efficient in young cattle. An associated DIVA test has just confirmed the interest of this vaccine.

Bovine syncytial Respiratory Virus (BRSv) is a major pathogen that causes bovine respiratory diseases, affecting mainly young cattle. Existing vaccines do not offer a satisfactory protection. As part of the European consortium SAPHIR, several candidate vaccines agains BRSv were tested on young cattle whose immunological characteristics associated with their young age represent a major obstacle to the efficacy of conventional vaccines. One of the major obstacles is to efficiently vaccine calves that possess interfering antibodies from their mothers.The results are from a partnership between INRA, the Pirbright Institute (UK), Swedish University of Agricultural Sciences (Suède), PME Ingenasa (Espagne), and the NIH (USA).

See also

Scientific Contact:

  • Sabine Riffault, UR0892 VIM

Partnership Contact:

  • Mustapha BERRI, Partnership and Innovation Officer

Modification date : 02 November 2023 | Publication date : 26 June 2020 | Redactor : SAPS - Edition P. Huan - Translation W. Brand-Williams